« Return to News | Miscellaneous

Covance Revenue Up 8% in ‘09, Plans for 10% Growth in ‘10

Thursday, January 28, 2010 02:55 PM

Covance reported fourth-quarter revenue growth of 11% to $507 million, largely due to the positive impact of foreign exchange.

The CRO’s revenues grew 8% in 2009. Year-end revenues were $1.96 billion in 2009 compared with $1.83 billion in 2008. Operating margin was 11.3%.  Earnings per share were $2.73 for the year and $0.64 per diluted share for the fourth quarter.

Covance expects full-year revenue growth in 2010 to be 10% over 2009, and earnings per share to be in the range of $2.50 to $2.75.

Covance’s late-stage business, including central laboratory, phase II and III clinical development and commercialization services, jumped 26% in the fourth quarter to $282 million. Full-year net revenues grew 22% to $1.1 billion compared to $883.3 million in 2008.  

The company’s early-development segment did not fare as well, with revenues down 5% to $203 million from the fourth quarter last year.  Full year net revenues in this segment declined 6% to $792 million compared with $845 million in 2008.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.